• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Bigfoot Biomedical diabetes management program rolls out in some U.S. states

June 24, 2021 By Sean Whooley

Bigfoot Biomedical smart insulin pen cap
[Image from Bigfoot Biomedical]
Bigfoot Biomedical announced today that made its Bigfoot Unity diabetes management program available in select U.S. markets.

Milpitas, Calif.-based Bigfoot’s program is now available in California, Texas, Florida, Pennsylvania, Ohio, New York, New Jersey, Massachusetts and other New England states. The program is offered as a bundle of devices, supplies and services and delivered as a 30-day subscription to eliminate upfront costs. Bigfoot Unity is eligible for insurance coverage and generally should be covered by insurance, although copays vary.

According to a news release, the availability of the Bigfoot Unity program, which received FDA clearance last month, will expand to other markets throughout 2021 and 2022.

Bigfoot Unity, a first-of-its-kind system, features connected smart pen caps designed to recommend insulin doses for diabetes patients using multiple daily injection (MDI) therapy. The smart pen caps offer on-demand insulin dose decision support in an effort to minimize guesswork and help patients to follow their doctors’ instructions.

The company touts the Unity system as the first and only solution for those 12 years old and up with type 1 and type 2 diabetes who are on MDI therapy that directly uses integrated continuous glucose monitoring system (iCGM) data from Abbott’s FreeStyle Libre 2 system to provide an insulin dose recommendation.

“As an industry, we need to fix the broken therapy cycle for treating diabetes so both patients and clinicians can be successful in realizing better outcomes,” Bigfoot Biomedical CEO Jeffrey Brewer said in the release. “With these innovative, connected technologies, we can address many of the challenges faced by clinicians. Our Bigfoot Unity program is designed to act as a real-time partner in diabetes management so clinicians focus on what really matters.”

The Bigfoot Unity program centers around the Bigfoot Clinic Hub. The secure, cloud-based platform takes passively captured and uploaded data from the Bigfoot Unity and FreeStyle Libre 2 to allow for providers to make informed, timely therapy adjustments while addressing potential issues between visits before they become critical, Bigfoot said.

For clinicians, the innovative approach of the Bigfoot Unity Program is centered around the Bigfoot Clinic Hub™, a secure, cloud-based platform. Data from their patients using the Bigfoot Unity System and a FreeStyle Libre 2 sensor is passively captured and uploaded to the Clinic Hub from the System’s smart pen caps whenever WiFi or cellular signal is present providing on-demand access.

“Advances in technology are moving at a rapid pace, necessitating a radical change in diabetes care,” Brewer added. “It’s long overdue, especially for those who rely on multiple daily injections of insulin and their clinicians.”

Filed Under: Auto-injectors, Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring Tagged With: Bigfoot Biomedical

IN CASE YOU MISSED IT

  • Glucotrack to effect a reverse stock split
  • Medtronic unveils ‘MiniMed’ as name for soon-to-be separated Diabetes unit
  • Insulet, Marvel collab to unveil comic book hero with type 1 diabetes
  • Insulet rolls out new Omnipod 5 iPhone app for use with Dexcom G7
  • Tandem, Abbott strike deal to pair insulin pumps with glucose-ketone monitor

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at swhooley@wtwhmedia.com.

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS